# ZURA (Zura Bio Limited) - SEC EDGAR Financial Statements

> Zura Bio Limited reported $194.6M in total assets and a net loss of $93.53M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ZURA
- Markdown: https://convexityos.com/fundamentals/ZURA.md
- SEC CIK: 0001855644
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:47 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001855644&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$102.0M | Operating profit |
| Net Income | FY 2025 | -$93.53M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.73 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$64.94M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $187.7M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Research & Development | $42.08M | $24.40M | $44.00M | $23.69M |
| Total Operating Expenses | $75.25M | $55.19M | $62.64M | $27.16M |
| **Operating Income** | -$75.25M | -$55.19M | -$62.64M | -$27.16M |
| **EBITDA** | -$75.20M | -$55.18M | -- | -- |
| Interest Income | $6.34M | $8.00M | $2.19M | $8.0K |
| Income Before Tax | -$68.65M | -$52.40M | -$60.56M | -$27.33M |
| Income Tax Expense | -- | $0 | $0 | -- |
| **Net Income** | -$68.65M | -$52.40M | -$60.36M | -$25.74M |
| Basic EPS | -$1.06 | -$0.60 | -$2.09 | -$141.97 |
| **Diluted EPS** | -$1.06 | -$0.60 | -$2.09 | -$141.97 |
| Basic Shares Outstanding | 94.2M | 75.1M | 33.1M | 228.1K |
| Diluted Shares Outstanding | 94.2M | 75.1M | 33.1M | 228.1K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $19.49M | $20.71M | $14.75M | $10.96M | $11.95M | $8.70M | $10.47M | $9.24M |
| Total Operating Expenses | $28.77M | $29.32M | $25.50M | $18.41M | $19.52M | $18.06M | $19.25M | $15.73M |
| **Operating Income** | -$28.77M | -$29.32M | -$25.50M | -$18.41M | -$19.52M | -$18.06M | -$19.25M | -$15.73M |
| **EBITDA** | -$28.77M | -$29.34M | -$25.48M | -$18.36M | -$19.52M | -$18.07M | -$19.25M | -- |
| Interest Income | $1.76M | $1.92M | $1.32M | $1.28M | $1.53M | $1.72M | $1.82M | $2.13M |
| Income Before Tax | -$27.05M | -$26.39M | -$24.22M | -$17.18M | -$18.04M | -$15.99M | -$17.44M | -$13.62M |
| Income Tax Expense | -$1.22M | -$81K | $0 | -- | $0 | $0 | $0 | -- |
| **Net Income** | -$25.82M | -$26.30M | -$24.22M | -$17.18M | -$18.04M | -$15.99M | -$17.44M | -$13.62M |
| Basic EPS | -$0.20 | -$0.21 | -$0.22 | -- | -$0.21 | -$0.17 | -$0.19 | -- |
| **Diluted EPS** | -$0.20 | -$0.21 | -$0.22 | -- | -$0.21 | -$0.17 | -$0.19 | -- |
| Basic Shares Outstanding | 127.7M | 126.8M | 112.2M | -- | 94.6M | 94.3M | 93.0M | -- |
| Diluted Shares Outstanding | 127.7M | 126.8M | 112.2M | -- | 94.6M | 94.3M | 93.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $109.4M | $176.5M | $99.81M | $14K | $729K |
| **Cash & Short-Term Investments** | $109.4M | $176.5M | $99.81M | $14K | $729K |
| **Total Current Assets** | $112.3M | $178.7M | $100.8M | $1.78M | $1.15M |
| Property, Plant & Equipment, Net | $126K | $91K | -- | -- | -- |
| Other Non-Current Assets | $1.51M | $698K | -- | -- | -- |
| **Total Non-Current Assets** | $1.64M | $789K | $0 | $3.49M | $139.4M |
| **Total Assets** | $113.9M | $179.5M | $100.8M | $5.26M | $140.6M |
| Accounts Payable | $1.28M | $733K | $2.75M | $2.01M | $70K |
| **Total Current Liabilities** | $12.41M | $19.51M | $20.30M | $14.82M | $272K |
| **Total Non-Current Liabilities** | $0 | $0 | $990K | $0 | $10.08M |
| **Total Liabilities** | $12.41M | $19.51M | $21.29M | $14.82M | $10.35M |
| Common Stock | $7.0K | $7.0K | $4.0K | -- | -- |
| Retained Earnings | -$224.5M | -$155.9M | -$103.5M | -$32.06M | -$9.18M |
| **Total Stockholders' Equity** | $101.5M | $146.8M | $59.33M | -$32.06M | -$9.18M |
| Total Equity | $101.5M | $148.4M | $60.87M | -$32.06M | -$9.18M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $187.7M | $205.1M | $225.6M | $109.4M | $139.0M | $154.5M | $170.6M | $176.5M |
| **Cash & Short-Term Investments** | $187.7M | $205.1M | $225.6M | $109.4M | $139.0M | $154.5M | $170.6M | $176.5M |
| **Total Current Assets** | $191.6M | $210.5M | $227.0M | $112.3M | $142.3M | $157.0M | $171.7M | $178.7M |
| Property, Plant & Equipment, Net | $153K | $149K | $125K | $126K | $131K | $122K | $106K | $91K |
| Other Non-Current Assets | $2.88M | $2.75M | $1.51M | $1.51M | $1.51M | $698K | $698K | $698K |
| **Total Non-Current Assets** | $3.04M | $2.90M | $1.64M | $1.64M | $1.64M | $820K | $804K | $789K |
| **Total Assets** | $194.6M | $213.4M | $228.6M | $113.9M | $143.9M | $157.8M | $172.5M | $179.5M |
| Accounts Payable | $758K | $3.28M | $2.08M | $1.28M | $3.27M | $1.21M | $1.25M | $733K |
| **Total Current Liabilities** | $16.97M | $16.32M | $11.74M | $12.41M | $25.49M | $18.70M | $21.09M | $19.51M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $16.97M | $16.32M | $11.74M | $12.41M | $25.49M | $18.70M | $21.09M | $19.51M |
| Common Stock | $10K | $10K | $9.0K | $7.0K | $7.0K | $6.0K | $7.0K | $7.0K |
| Retained Earnings | -$300.9M | -$275.1M | -$248.8M | -$224.5M | -$207.4M | -$189.3M | -$173.3M | -$155.9M |
| **Total Stockholders' Equity** | -- | -- | -- | $101.5M | $108.2M | $125.9M | $138.2M | $146.8M |
| Total Equity | $177.7M | $197.1M | $216.9M | $101.5M | $109.8M | $127.4M | $139.7M | $148.4M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$68.65M | -$52.40M | -$60.56M | -$27.33M |
| Depreciation & Amortization | $49K | $9.0K | -- | -- |
| Stock-Based Compensation | $12.33M | $16.80M | $7.47M | $334K |
| Change in Payables | -- | -- | -- | $212K |
| **Operating Cash Flow** | -$64.81M | -$28.08M | -$15.05M | -$1.20M |
| Capital Expenditure | -$113K | -$75K | -- | -- |
| **Free Cash Flow** | -$64.93M | -$28.15M | -- | -- |
| **Investing Cash Flow** | -$113K | -$5.08M | -$8.00M | -$12.00M |
| Common Stock Issued | -- | -- | $56.68M | -- |
| **Financing Cash Flow** | -$2.16M | $109.8M | $121.3M | $14.77M |
| **Net Change in Cash** | -$67.09M | $76.69M | $98.24M | -$715K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$26K | $24.17M | -$24.22M | -$68.60M | -$18K | $17.41M | -$17.44M | -$13.62M |
| Depreciation & Amortization | $20 | -$16K | $16K | $49K | $14 | -$9.0K | $9.0K | -- |
| Stock-Based Compensation | $5.3K | -$5.00M | $5.01M | $12.32M | $2.4K | -$3.64M | $3.64M | $2.82M |
| **Operating Cash Flow** | -$19K | $18.88M | -$18.92M | -$64.77M | -$15K | $11.04M | -$11.06M | -$10.82M |
| Capital Expenditure | -$36 | $13K | -$13K | -$113K | -$32 | $49K | -$49K | -$45K |
| **Free Cash Flow** | -$20K | $18.90M | -$18.94M | -$64.89M | -$15K | $11.08M | -$11.11M | -$10.87M |
| **Investing Cash Flow** | -$36 | $13K | -$13K | -$113K | -$32 | $49K | -$49K | -$45K |
| **Financing Cash Flow** | $2.1K | -$135.0M | $135.1M | -$2.17M | $3 | -$5.18M | $5.18M | -- |
| **Net Change in Cash** | -$17K | -$116.1M | $116.2M | -$67.05M | -$15K | $5.91M | -$5.93M | -$11.72M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -67.6% | -35.7% | -101.7% | -- |
| Return on Assets (ROA) | -60.2% | -29.2% | -59.9% | -489.1% |
| Current Ratio | 9.05x | 9.16x | 4.97x | 0.12x |
| Quick Ratio | 8.82x | 9.04x | 4.92x | 0.00x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -67.6% | -60.1% | -53.8% | -44.9% | -35.7% |
| Return on Assets (ROA) | -48.1% | -40.2% | -33.0% | -60.2% | -45.2% | -42.9% | -36.0% | -29.2% |
| Current Ratio | 11.29x | 12.90x | 19.33x | 9.05x | 5.58x | 8.40x | 8.14x | 9.16x |
| Quick Ratio | 11.06x | 12.57x | 19.21x | 8.82x | 5.45x | 8.26x | 8.09x | 9.04x |
| Operating Cash Flow Growth (YoY) | -- | +71.1% | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | +70.5% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
